Literature DB >> 11585786

Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans.

J Lou1, R Lucas, G E Grau.   

Abstract

Malaria still is a major public health problem, partly because the pathogenesis of its major complication, cerebral malaria, remains incompletely understood. Experimental models represent useful tools to better understand the mechanisms of this syndrome. Here, data generated by several models are reviewed both in vivo and in vitro; we propose that some pathogenic mechanisms, drawn from data obtained from experiments in a mouse model, may be instrumental in humans. In particular, tumor necrosis factor (TNF) receptor 2 is involved in this syndrome, implying that the transmembrane form of TNF may be more important than the soluble form of the cytokine. It has also been shown that in addition to differences in immune responsiveness between genetically resistant and susceptible mice, there are marked differences at the level of the target cell of the lesion, namely, the brain endothelial cell. In murine cerebral malaria, a paradoxical role of platelets has been proposed. Indeed, platelets appear to be pathogenic rather than protective in inflammatory conditions because they can potentiate the deleterious effects of TNF. More recently, it has been shown that interactions among platelets, leukocytes, and endothelial cells have phenotypic and functional consequences for the endothelial cells. A better understanding of these complex interactions leading to vascular injury will help improve the outcome of cerebral malaria.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585786      PMCID: PMC89004          DOI: 10.1128/CMR.14.4.810-820.2001

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  119 in total

1.  Respective role of TNF receptors in the development of experimental cerebral malaria.

Authors:  R Lucas; J N Lou; P Juillard; M Moore; H Bluethmann; G E Grau
Journal:  J Neuroimmunol       Date:  1997-02       Impact factor: 3.478

2.  Cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelium is regulatable by cytokines and phorbol ester.

Authors:  J K Johnson; R A Swerlick; K K Grady; P Millet; T M Wick
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

Review 3.  Cerebral malaria.

Authors:  G Turner
Journal:  Brain Pathol       Date:  1997-01       Impact factor: 6.508

4.  Multiple adhesive phenotypes linked to rosetting binding of erythrocytes in Plasmodium falciparum malaria.

Authors:  V Fernandez; C J Treutiger; G B Nash; M Wahlgren
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  T lymphocyte-dependent development of cerebral symptoms in WM/Ms rats infected with Plasmodium berghei.

Authors:  Y Imai; T Kamiyama
Journal:  Ann Trop Med Parasitol       Date:  1994-02

6.  Cytokine profile suggesting that murine cerebral malaria is an encephalitis.

Authors:  V M Jennings; J K Actor; A A Lal; R L Hunter
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

7.  TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense.

Authors:  S Steinshamn; M H Bemelmans; L J van Tits; K Bergh; W A Buurman; A Waage
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

8.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

9.  Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections.

Authors:  I Garcia; Y Miyazaki; K Araki; M Araki; R Lucas; G E Grau; G Milon; Y Belkaid; C Montixi; W Lesslauer
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

10.  Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites.

Authors:  L Schofield; F Hackett
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  94 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria.

Authors:  Matthew A Huggins; Holly L Johnson; Fang Jin; Aurelie N Songo; Lisa M Hanson; Stephanie J LaFrance; Noah S Butler; John T Harty; Aaron J Johnson
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

3.  Serum tumour necrosis factor alpha levels in severe malaria: effect of partial exchange transfusion.

Authors:  Sanjeev Kumar; Dilip R Karnad; Janhavi Vaingankar; Urmila M Thatte; Anand Krishnan; Nirmala N Rege
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

4.  Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities.

Authors:  Chek Meng Poh; Shanshan W Howland; Gijsbert M Grotenbreg; Laurent Rénia
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

5.  In vivo anti-malarial effect of the beta-amino alcohol 1t on Plasmodium berghei.

Authors:  N Bahamontes-Rosa; K Bucher; J Held; A Robin; W H Hoffmann; S L Flitsch; P G Kremsner; J F J Kun
Journal:  Parasitol Res       Date:  2009-01-27       Impact factor: 2.289

6.  Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria.

Authors:  Fiona E Lovegrove; Sina A Gharib; Samir N Patel; Cheryl A Hawkes; Kevin C Kain; W Conrad Liles
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

7.  Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.

Authors:  Sylvie Briquet; Nadou Lawson-Hogban; Bertrand Boisson; Miguel P Soares; Roger Péronet; Leanna Smith; Robert Ménard; Michel Huerre; Salah Mécheri; Catherine Vaquero
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

8.  FTIR imaging of brain tissue reveals crystalline creatine deposits are an ex vivo marker of localized ischemia during murine cerebral malaria: general implications for disease neurochemistry.

Authors:  Mark J Hackett; Joonsup Lee; Fatima El-Assaad; James A McQuillan; Elizabeth A Carter; Georges E Grau; Nicholas H Hunt; Peter A Lay
Journal:  ACS Chem Neurosci       Date:  2012-09-11       Impact factor: 4.418

9.  Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Authors:  Roberta Spaccapelo; Chris J Janse; Sara Caterbi; Blandine Franke-Fayard; J Alfredo Bonilla; Luke M Syphard; Manlio Di Cristina; Tania Dottorini; Andrea Savarino; Antonio Cassone; Francesco Bistoni; Andrew P Waters; John B Dame; Andrea Crisanti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

10.  Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model.

Authors:  Jérome Dormoi; Sébastien Briolant; Camille Desgrouas; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.